Clinical Trial Update: Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial updating on the safety and activity of vorinostat in combination with trastuzumab for metastatic or locally recurrent breast cancer. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)
• Vorinostat (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer, Male Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-09-27